Nureca Ltd.

374.45 -23.60 ▼-5.9%

04 October 2023, 04:01:00 PM
Volume: 31,932

Company Profile

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.nureca.com
Market Cap 378.66 Cr.
Enterprise Value(EV) 327.17 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -4.83 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 62.29 Trailing Twelve Months Ending 2023-06
Book Value / Share 194.17 Trailing Twelve Months Ending 2023-06
Price to Book Value 1.95 Calculated using Price: 378.65
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.00 Cr. 10,000,175 Shares
FaceValue 10
About Nureca Ltd.
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in.

Nureca Ltd. Delivery

Delivered Qty
Traded Qty

Nureca Ltd. Performance

1 Day
-5.93%
1 Week
+10.96%
1 Month
+15.20%
3 Month
+1.75%
6 Month
+20.95%
1 Year
-57.56%
2 Year
-76.89%
5 Year
10 Year

Nureca Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 426.30 162.03 61.23 52.39 24.55 -4.14
Return on Capital Employed (%) 255.06 179.97 56.70 67.61 33.57 -5.17
Return on Assets (%) 44.35 40.78 22.30 41.38 20.33 -3.62

Nureca Ltd. Balance Sheet

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 2 8 15 163 203 195
Non Curr. Liab. 0 0 9 3 4 0
Curr. Liab. 5 15 10 24 45 9
Minority Int.
Equity & Liab. 7 24 34 190 252 204
Non Curr. Assets 0 1 1 4 13 17
Curr. Assets 7 23 33 186 239 187
Misc. Exp. not W/O
Total Assets 7 24 34 190 252 204

Nureca Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 20 62 99 213 256 111 107
Other Income 0 0 0 3 8 7 9
Total Income 20 62 99 216 263 118 116
Total Expenditure -16 -53 -90 -152 -200 -126 -119
PBIDT 4 9 10 64 63 -8 -4
Interest 0 0 -1 -2 -1 0 0
Depreciation 0 0 0 0 -1 -2 -2
Taxation -1 -3 -2 -16 -16 2 2
Exceptional Items
PAT 3 6 6 46 45 -8 -5
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 3 6 6 46 45 -8 -5
Adjusted EPS 445 889 914 46 45 -8 -5

Nureca Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -8 35 1 10
Cash Fr. Inv. 0 0 0 -110 -3 -16
Cash Fr. Finan. 0 0 8 92 -7 -2
Net Change 0 0 0 17 -9 -8
Cash & Cash Eqvt 0 0 0 17 8 1

Nureca Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 70.00 70.00 70.00 70.00 70.00 70.00 62.98 62.98 62.98
Public 30.00 30.00 30.00 30.00 30.00 30.00 37.02 37.02 37.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Nureca Ltd. Announcements

Sat, 30 Sep 2023
Closure of Trading Window
Trading window for dealing in the equity shares of the Company will remain closed from October 1 2023 till the completion of 48 hours after the declaration of unaudited financial results for the quater and half year ended on September 30 2023
Thu, 07 Sep 2023
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
This is to inform you that Mr. Nishant Garg - Chief Financial Officer and Key Managerial Personnel has tendered his resignation vide mail dated September 7 2023 and he will be relived from his duties effective end of business hours of December 6 2023.
Fri, 11 Aug 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosed copies of newspaper publications for the unaudited financial results for the quarter ended June 30 2023

Nureca Ltd. Technical Scans

Tue, 03 Oct 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month High Close Crossing Last Month High

Nureca Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,792.80 3,702.05 -0.5%
Cipla Ltd. 95,478.34 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,048.70 -1.4%
Mankind Pharma Ltd. 72,079.88 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,636.20 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.69 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.92 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Nureca Ltd. FAQ's

What is Nureca Ltd. share price?

Can I buy Nureca Ltd. shares now?

What is the Market Cap of Nureca Ltd.?

What are the key metrics to analyse Nureca Ltd.?

What is the 52 Week High and Low of Nureca Ltd.?

What is the trend of Nureca Ltd. share price?